Press
Releases
2006
May 1, 2006
Healthtrust Purchasing
Group selects ONCURA™ to provide membership with
prostate brachytherapy products under a new three-year
agreement
January 31, 2006
ONCURA™ Wins
Contract for The Cookridge Hospital’s Prostate
Brachytherapy Seed Business
2005
August 19, 2005
Amerinet
selects ONCURA™ to provide Prostate Brachytherapy
products under a new three-year agreement
July 21, 2005
ONCURA™
Announces an Agreement with North American Scientific
Inc. for the Distribution of Prospera® Palladium-103
Prostate Brachytherapy Sources
July 12, 2005
The Centers
for Medicare and Medcaid Services (CMS) Adds Cryosurgical
Ablation of the Prostate to the Ambulatory Surgery Center
(ASC) List of Medicare Covered Procedures
June 2005
View
WGN News Report June 2005
June 13, 2005
ONCURA™ Announces French Reimbursement for Their Leading
Prostate Cancer Treatment Products.
June 1, 2005
ONCURA™ Expands its Product Line with RAPID Strand™ Rx.
May 25, 2005
Dr Aaron Katz of Columbia Presbyterian Presents 10-Year
Prostate Cryotherapy Data at the Amercian Urological
Association (AUA) Annual Meeting in San Antonio.
March 14, 2005
Oncura™ Announces That Dr. Aaron Katz of Columbia Presbyterian Has Treated Over 50 Prostate Cancer Patients With The SeedNet™ Cryotherapy System.
2004
December 10, 2004
ONCURA™
Confirms That They Will Not Renew US Distribution Agreement
with Theragenics™ When it Expires in December
2005.
December 9, 2004
Clinical
Study Demonstrates that ONCURA's RAPID Strand™
Offers Improved Delivery of Therapy for Patients Choosing
Brachytherapy to Treat Prostate Cancer.
November 24, 2004
The European
Collaborative Group on Prostate Brachytherapy Reports
on over 1150 Patients Treated with Oncura's RAPID Strand™.
October 28, 2004
Oncura™
elevated to the status of Ambassador Supporter by the
American Society of Therapeutic Radiology and Oncology
(ASTRO).
October 5, 2004
Long-term
data presentated by the New York Prostate Institute
and utilizing ONCURA's OncoSeed™ reinforces the
value of Prostate Brachytherapy.
September 28, 2004
ONCURA™ Introduces
the IceRod™, a New Minimally Invasive 17 Gauge
Cryoneedle with Increased Therapeutic Coverage.
September 23, 2004
ONCURA™
Successfully Completes SeedNet™!" Installation
at Columbia Presbyterian with Dr. Katz using the new
17 gauge IceRod™ technology.
June 9, 2004
Premier
selects Oncura to provide membership with exclusive
prostate brachytherapy products under two new three-year
agreements.
May 25, 2004
New data
presented at the annual meeting of the American Brachytherapy
Society demonstrates the value of RAPID Strand™
as a treatment for localized prostate cancer.
May 20, 2004
ONCURA™
introduces innovations in prostate cancer cryotherapy
at the annual meeting of the American Urological Association.
May 11, 2004
Long-term
data utilizing ONCURA’s OncoSeed™ reinforces
the value of Iodine-125 prostate brachytherapy.
April 28, 2004
Long
term cancer survival data utilizing ONCURA's OncoSeed™
reinforces brachytherapy's position as standard of care
for treating prostate cancer.
2003
October 17, 2003
Journal of Urology publication
reports preliminary multi-center data using ONCURA’s
ultra-thin, 17 gauge technology as a minimally invasive
treatment option for prostate cancer.
October 02, 2003
RAPID
Strand™ offers increased clinical confidence to
prostate cancer patients treated with brachytherapy.
August 13, 2003
Three major hospitals
in the UK adopt cryotherapy as a minimally invasive
treatment option for prostate cancer patients.
July 16, 2003
Cryotherapy confirmed
as a reimbursed treatment for localized prostate cancer
by Blue Cross Blue Shield of Texas.
July 08, 2003
Merger Creates ONCURA,
a Global Leader in Minimally Invasive Prostate Cancer
Disease Management.
|
